Anti-fungal therapy at the HAART of viral therapy

Active human immunodeficiency virus protease is required for viral infectivity.

1988 • 1,309 citations

Virulence factors of Candida albicans

2001 • 1,289 citations

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

1989 • 831 citations

PEPSTATIN, A NEW PEPSIN INHIBITOR PRODUCED BY AGTINOMYGETES

1970 • 653 citations

The Structure and Function of the Aspartic Proteinases

1990 • 637 citations

Evolution in the structure and function of aspartic proteases

1987 • 298 citations

Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence

1997 • 297 citations

A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence

1997 • 277 citations

Multiplicity of genes encoding secreted aspartic proteinases in Candida species

1994 • 251 citations

Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis

1999 • 226 citations

In Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors

1999 • 215 citations

Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats

1997 • 201 citations

In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis

1999 • 194 citations

Three distinct secreted aspartyl proteinases in Candida albicans

1993 • 163 citations

Differential activation of a Candida albicans virulence gene family during infection

2000 • 150 citations

Role of Protease Inhibitors in Preventing Recurrent Oral Candidosis in Patients With HIV Infection: A Prospective Case-Control Study

1999 • 136 citations

Sequence of the Candida albicans gene encoding the secretory aspartate proteinase.

1991 • 133 citations

Effects of the Human Immunodeficiency Virus (HIV) Proteinase Inhibitors Saquinavir and Indinavir on In Vitro Activities of Secreted Aspartyl Proteinases of Candida albicans Isolates from HIV-Infected Patients

1999 • 132 citations

Differential regulation of SAP8 and SAPS, which encode two new members of the secreted aspartic proteinase family in Candida albicans

1998 • 131 citations

Targeting the HIV-protease in AIDS therapy: a current clinical perspective

2000 • 131 citations

Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus

1996 • 123 citations

HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases

1999 • 119 citations

Development of Drug Resistance to HIV-1 Protease Inhibitors

1995 • 114 citations

Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes

1993 • 108 citations

Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients

1995 • 106 citations

Role of aspartic proteases in disseminated Candida albicans infection in mice

1997 • 102 citations

Sequence of theCandida albicansgene encoding the secretory aspartate proteinase

1991 • 91 citations

A second gene for a secreted aspartate proteinase in Candida albicans

1992 • 90 citations

HIV protease inhibitors attenuate adherence ofCandida albicansto epithelial cells in vitro

2001 • 78 citations

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

1999 • 70 citations

In Vivo Expression and Localization of Candida albicans Secreted Aspartyl Proteinases during Oral Candidiasis in HIV-Infected Patients

1999 • 66 citations

Modulation of Experimental Systemic Murine Candidosis by Intravenous Pepstatin

1990 • 63 citations

HIV protease inhibitors influence the prevalence of oral candidosis in HIV‐infected patients: a 2‐year study

1998 • 61 citations

A second front against AIDS

1989 • 52 citations

High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women

1999 • 50 citations

Dissimilar Attenuation of Candida albicans Virulence Properties by Human Immunodeficiency Virus Type 1 Protease Inhibitors

1999 • 40 citations

In Vitro Activity of Human Immunodeficiency Virus Protease Inhibitors againstPneumocystis carinii

2000 • 40 citations

The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.

1999 • 23 citations

Relationship between fluconazole sensitivity ofCandida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count

1994 • 21 citations

Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)‐infected patient upon combination treatment with an HIV protease inhibitor

1998 • 12 citations

HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro

2001 • 9 citations